Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EuroEyes International Eye Clinic Limited ( (HK:1846) ) has shared an announcement.
EuroEyes International Eye Clinic Limited has announced an interim cash dividend of HKD 0.0315 per share for the six months ending June 30, 2025. This move signifies the company’s stable financial performance and commitment to returning value to its shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, specializing in eye care services. The company focuses on providing advanced eye treatment solutions, including laser eye surgery and lens implantations, catering to a market that seeks high-quality vision correction services.
Average Trading Volume: 159,698
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.01B
See more data about 1846 stock on TipRanks’ Stock Analysis page.